ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
86
views
0
references
Top references
cited by
347
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,728
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Author(s):
Ronald van Vollenhoven
,
Roy Fleischmann
,
Stanley Cohen
,
Eun Bong Lee
,
Juan García Meijide
,
Sylke Wagner
,
Sarka Forejtova
,
Samuel H Zwillich
,
David Gruben
,
Tamas Koncz
,
Gene Wallenstein
,
Sriram Krishnaswami
,
John Bradley
,
Bethanie Wilkinson
Publication date:
2012-08-09
Journal:
New England Journal of Medicine
Publisher:
New England Journal of Medicine (NEJM/MMS)
Read this article at
ScienceOpen
Publisher
Further versions
open (via free article)
Powered by
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Procedural speed in criminal law
Author and article information
Journal
DOI::
10.1056/NEJMoa1112072
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,728
Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015
Authors:
Toshinobu Matsui
,
Ryogo UMETSU
,
Yamato KATO
…
UT6 IMPROVEMENT IN HEALTH UTILITY AMONG RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED WITH ADALIMUMAB (D2E7), A FULLY HUMAN ANTI-TNF MONOCLONAL ANTIBODY
Authors:
L van de Putte
,
R. Boggs
,
N. Sengupta
…
Crohn's Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab.
Authors:
Mark T Osterman
,
William J Sandborn
,
Jean-Frédéric Colombel
…
See all similar
Cited by
340
Diagnosis and Management of Rheumatoid Arthritis
Authors:
Daniel Aletaha
,
Josef Smolen
JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
Authors:
Shubhasree Banerjee
,
Ann Biehl
,
Massimo Gadina
…
Novel treatment strategies in rheumatoid arthritis
Authors:
Gerd Burmester
,
Janet E. Pope
See all cited by
Version 1
Version 1
Version 1